Phase I studies
  • Alzheimer’s disease (Including FIH)Top 2 in number of subjects enrolled globally.
  • Glaucoma, ocular hypertension,
  • Type1 DM, Type2 DM
  • Healthy volunteers (including FIH),30-days admission, DDI studies, etc.
  • Healthy elderly volunteers48 beds occupied at a time, 24-days of admission
Phase II, III studies
  • Pre-Alzheimer’s diseasePsychiatrist and clinical psychologist
  • Type1 DM, Type2 DM
  • Bronchial asthma12-hour repeated spirometry
  • Osteoarthritis53 subjects enrolled in 4 months.
Patient PK studies and others
  • Hyperuricemia24 subjects with overproduction of uric acid.Obtained 380 written informed consents in 10 months.
  • Chemotherapeutics for cancer patients
  • Bronchial asthma12-hour repeated spirometry
  • BE study for Post-menopausal women360 subjects (180 × 2 times)